Economy and macroUpdated 1h ago

Survey estimates put the share of GLP-1 users who reported taking it differently from prescribed at 44%.

A skipped dose, a delayed refill, a smaller dose: those were among the ways people reported using GLP-1 medication differently from prescribed. A study published in the CDC’s Morbidity and Mortality Weekly Report analyzed self-reported responses from more than 8,000 U.S. adults collected in July and August 2025. Researchers estimated that 44% of GLP-1 users changed how they used the medication. The survey put overall use at about 27 million U.S. adults, or 9.8%, in 2025. More than half of the users who changed their routine cited cost or availability. For many, paying for or getting the medication had a say in how they took it.

1 publisher1 report

Coverage started 1h ago